Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity
about
Impairment of myocardial contractility by anticancer anthracyclines: role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogueAn essential difference between the flavonoids monoHER and quercetin in their interplay with the endogenous antioxidant networkEvaluation of the mutagenicity and antimutagenicity of Ziziphus joazeiro Mart. bark in the micronucleus assay.Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials.Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis.UVRAG Deficiency Exacerbates Doxorubicin-Induced Cardiotoxicity.The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review.The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.Protectors against doxorubicin-induced cardiotoxicity: flavonoids.Protective action of hydroxyethyl rutosides on singlet oxygen challenged cardiomyocytes.Histamine 2 receptor antagonism elicits protection against doxorubicin-induced cardiotoxicity in rodent model.A phase I study of monohydroxyethylrutoside in healthy volunteers.Protective Effect of Dietary Ghrelin-Containing Salmon Stomach Extract on Mortality and Cardiotoxicity in Doxorubicin-Induced Mouse Model of Heart Failure.
P2860
Q28363755-D6B042F2-7F36-4038-B211-7573B84D41C6Q28476023-14260CEE-1AD6-476F-874B-B0B9C2FC300AQ33890365-53594396-DEE1-4E49-AF9E-A6FDC05C0892Q36568908-0C542EE1-2A5D-45DE-B498-22D4C98129ECQ36891774-2CB72C2F-B815-450F-A479-9673E65B705BQ37571709-8A353A2D-46F2-47B5-895F-950BDC612525Q37658559-35E1C6D7-E914-4A48-AFB4-3544DBA0EB67Q38875916-0F160C72-D71B-4431-A048-EBBF7863C057Q39404639-76D64754-2E77-4D1F-81E5-4F267DA135D0Q40216079-360CC730-5F0C-4348-A893-C2B6F7657395Q42093186-CE976616-0976-404B-8B2B-555B7D03BC36Q46309853-8A03B152-FDC1-43FC-983C-49F980121831Q46681853-D8A17B53-6B90-4A6D-9A6F-5AF4039DE431Q53807749-4172DE16-90CE-43E9-8E06-96954FC64282
P2860
Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity
@ast
Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity
@en
type
label
Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity
@ast
Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity
@en
prefLabel
Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity
@ast
Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity
@en
P2093
P2860
P1476
Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity
@en
P2093
J A Grimbergen
S A van Acker
W J van der Vijgh
P2860
P304
P356
10.1111/J.1476-5381.1995.TB15034.X
P407
P577
1995-08-01T00:00:00Z